Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Sci. STKE, 11 December 2001 REVIEWSVEGF Receptor Signal TransductionTaro Matsumoto and Lena Claesson-Welsh* Department of Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Dag Hammarskjöldsv. 20, 751 85 Uppsala, Sweden. Gloss: Vascular endothelial growth factors (VEGFs) constitute an expanding family of growth factors that have received considerable attention from the basic research community but also from clinically active scientists and pharmaceutical companies. The reason for the interest in this growth factor family is its pivotal role in formation of the vascular tree during embryogenesis, as well as in formation of new vessels from preexisting ones, a process called angiogenesis. Normally, angiogenesis is tightly regulated, but in diseases such as cancer, diabetes, and chronic inflammatory diseases, excess VEGF is produced, leading to hyperstimulated and dysfunctional vessels. VEGF proteins bind to cell surface-expressed receptor molecules, denoted VEGF receptor-1, -2, and -3. VEGF receptor-1 and -2 are expressed on endothelial cells in blood vessels, whereas VEGF receptor-3 is expressed on cells in lymphatic vessels. Inactivation of certain of the genes encoding the VEGF proteins or the VEGF receptors is incompatible with normal vascular development. This review outlines the current knowledge about the role of the VEGF proteins and VEGF receptors in the formation of new blood vessels. Corresponding author. E-mail: Lena.Welsh{at}genpat.uu.se
Citation: T. Matsumoto, L. Claesson-Welsh, VEGF Receptor Signal Transduction. Sci. STKE 2001, re21 (2001). The editors suggest the following Related Resources on Science sites:In Science Signaling
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882